Asia Pacific Production Animal Health Market (2025 - 2033) Size, Share & Trends Analysis Report By Animal Type (Poultry, Swine), By Product (Biologics, Pharmaceuticals, Diagnostics, Equipment & Disposables, Medicated Feed Additives), By Country, And Segment Forecasts

APAC Production Animal Health Market Summary

The Asia Pacific production animal health market size was estimated at USD 10.04 billion in 2024 and is projected to reach USD 22.23 billion by 2033, growing at a CAGR of 9.23% from 2025 to 2033. The industry is driven by the region’s large and dense livestock population, rising protein consumption, and growing disease burden among production animals.

Countries like India and China collectively account for over one-third of the global cattle population, fueling consistent demand for veterinary pharmaceuticals, vaccines, and diagnostics. Increasing incidences of transboundary and zoonotic diseases such as foot-and-mouth disease, avian influenza, and African swine fever have increased the need for preventive healthcare and disease control measures. Additionally, growing government initiatives are driving market growth. For instance, in March 2025, the Union Cabinet approved a revised Livestock Health and Disease Control Programme (LHDCP) with a budget of INR 3,880 crore (USD 453 Mn) for 2024-25 and 2025-26. The revamped scheme consists of three core components: the National Animal Disease Control Programme (NADCP), Livestock Health & Disease Control (LH&DC), and the newly launched Pashu Aushadhi initiative. Key focus elements include mass vaccinations, deployment of mobile veterinary units, and distribution of affordable generic veterinary medicines through PM-Kisan Samriddhi Kendras (Centers) and cooperatives. 

The market is undergoing a significant transformation, with India emerging as a key driver through cohesive policy actions, international collaborations, and regulatory reforms. In 2025, India launched a series of strategic initiatives to strengthen veterinary infrastructure and service delivery. Notably, the Indian Council of Agricultural Research (ICAR) conducted a large-scale Animal Health Camp targeting marginalized farming communities, offering veterinary services and awareness programs under the Scheduled Caste Sub-Plan (SCSP). This field-level outreach reflects a growing governmental commitment to inclusive animal healthcare. 

Simultaneously, the Indian government introduced the USD 25 million ‘Animal Health Security Strengthening in India for Pandemic Preparedness and Response’ project, supported by the G20 Pandemic Fund, ADB, World Bank, and FAO. The initiative focuses on modernizing laboratory networks, improving surveillance systems, and upgrading digital disease reporting infrastructure, efforts expected to enhance preparedness for transboundary animal diseases across Asia. 

Regulatory advancements also underscore India’s evolving animal health landscape. The removal of the outdated Target Animal Batch Safety Test (TABST) by the Indian Pharmacopoeia Commission in July 2024 marked a key alignment with global best practices in vaccine safety, reducing unnecessary animal testing. Further, a landmark partnership between the Department of Animal Husbandry and Dairying (DAHD) and UNDP introduced an AI-enabled digital platform to track vaccine stock, distribution, and cold chain management, while leveraging the Animal Vaccine Intelligence Network (AVIN) to support livestock insurance and immunization coverage. These coordinated actions not only improve animal health outcomes in India but also reflect broader regional trends in the Asia Pacific, where digitalization, public-private collaboration, and regulatory modernization are shaping a more resilient and sustainable production animal health ecosystem. 

Market Concentration & Characteristics

The market is highly fragmented, and the pace of growth is accelerating. The market is dominated by global players such as Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco, and Ceva. These companies leverage strong R&D, broad portfolios, and global distribution networks to maintain competitiveness. 

Innovation is steadily rising, driven by the development of species-specific vaccines, advanced diagnostics (e.g., ELISA, PCR), and digital livestock monitoring tools. Local R&D efforts, particularly in India and China, are contributing to affordable, rapid diagnostic kits tailored to endemic diseases.

Mergers and acquisitions are moderate, with global companies acquiring local firms or forming partnerships to enhance distribution and regulatory compliance. Notable activity includes strategic expansions by Zoetis, Elanco, and Boehringer Ingelheim in India, Southeast Asia, and China. 

Regulatory frameworks significantly influence market dynamics, with strict controls on drug residues, antibiotic use, and environmental impact. For example, India banned veterinary use of Diclofenac and Nimesulide in 2025, affecting product portfolios and increasing the need for regulatory-aligned alternatives. 

Substitutes are limited for core veterinary pharmaceuticals and vaccines, though improvements in farm management, biosecurity, and alternative therapies (e.g., probiotics, herbal remedies) offer partial alternatives in disease prevention strategies. 

Regional expansion is strong, with both multinational and local firms investing in manufacturing, R&D, and distribution across high-growth markets like China, India, and Southeast Asia. Companies like Creso Pharma and Zoetis have expanded their presence through regional partnerships and localized product offerings.

Animal Type Insights

The cattle segment represented the largest share of 40.18% in 2024. This is attributed to the region's vast cattle population and the economic significance of dairy and beef production. Countries like India and China together host over 500 million cattle, representing more than one-third of the global bovine population, according to FAO estimates. This large base drives sustained demand for veterinary medicines, vaccines, reproductive aids, and diagnostic tools. In India, where dairy farming is a key livelihood for millions of smallholder farmers, cattle contribute over 60% of the country’s total milk production. Government-led initiatives such as mass vaccination programs for foot-and-mouth disease (FMD), brucellosis, and mastitis further boost the uptake of veterinary products in the segment. Moreover, rising per capita consumption of dairy products and increasing investments in organized dairy infrastructure across Southeast Asia and China have intensified the need for preventive and therapeutic health solutions in cattle, consolidating the segment’s dominance in the regional production animal health market. 

Fish are the fastest-growing segment in the market, driven by the rapid expansion of aquaculture across the region, particularly in countries like China, India, Vietnam, and Indonesia. Asia accounts for over 89% of global aquaculture production, with China alone contributing nearly 60%, according to the FAO's 2023 report. This surge in aquaculture activity has led to increased disease outbreaks, including bacterial, parasitic, and viral infections, driving demand for vaccines, antimicrobials, and water treatment products. The growing adoption of intensive farming systems and high stocking densities has further amplified the need for preventive fish health management. Governments across the region are actively promoting sustainable aquaculture practices, including fish health monitoring and biosecurity, while private investments in aquaculture R&D and diagnostic solutions have accelerated. These factors, combined with rising seafood consumption and export demand, are fueling the rapid growth of the fish segment within the animal health market.

Product Insights

Pharmaceuticals represented the largest segment in the market with a share of 40.53% in 2024, due to the region’s high prevalence of infectious and parasitic diseases in livestock and aquaculture. The widespread use of anti-infectives, anthelmintics, and anti-inflammatory drugs across intensive cattle, swine, and poultry production systems has sustained strong pharmaceutical demand. In countries like India and China, where livestock density is high and veterinary infrastructure is expanding, pharmaceuticals remain the primary mode of disease control and productivity enhancement. Additionally, increased awareness of animal disease management, rising veterinary drug approvals, and greater availability of generic veterinary medicines have supported market growth. Regulatory initiatives promoting livestock health, including mass deworming and antimicrobial use guidelines, have also contributed to the pharmaceutical segment’s dominance, making it the cornerstone of disease treatment and prevention in the region’s production animal health landscape.

Diagnostics has emerged as the fastest-growing segment in the Asia Pacific production animal health market, driven by rising demand for real-time, on-site disease detection and increasing regulatory emphasis on disease monitoring and surveillance. The growth is propelled by the expansion of large-scale commercial farming, where early diagnosis is critical to preventing economic losses from disease outbreaks. In aquaculture, where pathogens can spread rapidly, countries like Vietnam, Thailand, and Indonesia are increasingly investing in water quality and pathogen detection systems to maintain export standards. Additionally, government-supported initiatives such as the rollout of ELISA and PCR-based kits in India and the establishment of regional disease monitoring labs in China are improving access to advanced diagnostic technologies. The integration of digital tools and portable devices for herd-level screening is further accelerating adoption, making diagnostics essential for precision livestock farming and contributing to its rapid market growth across the region. 

Country Insights

China Production Animal Health Market Trends

The China production animal health market dominated the region with the largest revenue share of 22.55% in 2024, fueled by its vast livestock population, rising disease burden, and expanding domestic manufacturing capabilities. The country’s focus on controlling endemic diseases such as foot-and-mouth disease (FMD)-monitored by the National FMD Reference Laboratory-and outbreaks like H5 avian influenza, which saw 275 confirmed cases in Qinghai province in May 2024, has intensified demand for veterinary vaccines and diagnostics. Government-led disease control programs, increased veterinary healthcare spending, and strategic investments by global players have further strengthened the market. Additionally, China's growing pharmaceutical infrastructure and regulatory focus on biosecurity and food safety are accelerating the adoption of advanced animal health solutions across the swine, poultry, and ruminant sectors.

India Production Animal Health Market Trends

The production animal health market in India was shaped by the dominance of smallholder farmers, 88% of livestock are owned by families with holdings under 4 hectares, where livestock serves as a critical source of supplementary income. Livestock rearing is largely confined to rural and peri-urban areas, with the sector accounting for 50% of India’s total animal husbandry activity. The market is regulated by the Department of Animal Husbandry and the Drug Controller General of India (DCGI), which oversees veterinary product approvals. Recent regulatory actions, such as the bans on Nimesulide and Diclofenac for veterinary use due to environmental and wildlife safety concerns, have raised treatment costs and impacted disease management efficiency. Despite these challenges, the market is supported by strong government initiatives like the “Make in India” program, under which institutions like ICAR and IVRI have developed indigenous diagnostic kits such as Bluetongue sELISA and JE IgM ELISA. Additionally, the Central Institute for Research on Buffaloes introduced the Preg-D kit, a urine-based pregnancy detection tool. These advancements, alongside strategic expansions by major players such as Zoetis, Merck, Elanco, Boehringer Ingelheim, and Virbac, are expected to drive continued growth in India’s production animal health sector.

Indonesia Production Animal Health Market Trends

Indonesia production animal health market is experiencing steady growth, driven by government-led initiatives aimed at improving food security and nutrition. In January 2025, the government launched a USD 4.3 billion nutrition program targeting 19.5 million children and pregnant women, significantly increasing demand for dairy products. This surge has necessitated the import of dairy cattle and improvements in herd health to meet rising milk production needs. Concurrently, national policies promoting food self-sufficiency are supporting livestock sector expansion through genetic improvement programs and herd size enhancement. These developments are fueling demand for veterinary pharmaceuticals, vaccines, and diagnostic services to maintain animal health and productivity. For example, increased dairy imports have led to greater use of mastitis control treatments and reproductive health products to ensure milk yield targets are met.

Key Asia Pacific Production Animal Health Companies Insights

Key players operating in the Asia Pacific production animal health market are undertaking various initiatives to strengthen their presence and increase the reach of their products and services. Strategies such as expansion activities and partnerships are key in propelling the market growth.

Recent Developments

• In June 2025, Boehringer Ingelheim announced the launch of a next-generation, single-dose poultry vaccine in India that protects against Bursal disease, Newcastle disease, and Marek’s disease.

• In November 2024, Ceva Animal Health launches Ceva Genesys, an innovative system for automatic, precise separation of male and female broilers at hatch, enhancing flock uniformity and overall production efficiency.

• In April 2024, Zoetis sold its medicated feed additive portfolio, select water-soluble products, and related assets to Phibro Animal Health, streamlining its focus on core veterinary innovations.

Asia Pacific Production Animal Health Market Report Scope

Asia Pacific Production Animal Health Market Report Segmentation

This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Asia Pacific production animal health market report based on product, animal type, and country.

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Biologics

    • Vaccines

      • Modified/ Attenuated Live

      • Inactivated (Killed)

      • Other Vaccines

    • Other Biologics

  • Pharmaceuticals

    • Parasiticides

    • Anti-infectives

    • Anti-inflammatory

    • Analgesics

    • Others

  • Diagnostics

    • Consumables, reagents and kits

    • Instruments and devices

  • Equipment & Disposables

    • Critical Care Consumables

    • Anesthesia Equipment

    • Fluid Management Equipment

    • Temperature Management Equipment

    • Rescue & Resuscitation Equipment

    • Research Equipment

    • Patient Monitoring Equipment

  • Medicinal Feed Additives

  • Others

    • Veterinary Telehealth

    • Veterinary Software

    • Livestock Monitoring

• Animal Type Outlook (Revenue, USD Million, 2021- 2033)

  • Poultry

    • Biologics

      • Vaccines

        • Modified/ Attenuated Live

        • Inactivated (Killed)

      • Other Vaccines

      • Other Biologics 

    • Pharmaceuticals

      • Parasiticides

      • Anti-infectives

        • Antimicrobials

        • Anti-infectives except Antimicrobial

        • Anti-inflammatory

      • Analgesics

      • Others

    • Diagnostics

      • Consumables, reagents and kits

      • Instruments and devices

    • Equipment & Disposables

      • Critical Care Consumables

      • Anesthesia Equipment 

      • Fluid Management Equipment

      • Temperature Management Equipment

      • Rescue & Resuscitation Equipment

      • Research Equipment

      • Patient Monitoring Equipment

    • Medicinal Feed Additives

      • Anticoccidials

      • Pre/Probiotics & Phytotherapeutics

      • Performance enhancers (AGP)

      • Other

    • Others

      • Veterinary Telehealth

      • Veterinary Software

      • Livestock Monitoring

  • Swine

    • Biologics

      • Vaccines

        • Modified/ Attenuated Live

        • Inactivated (Killed)

        • Immunocastration

        • Other Vaccines

      • Other Biologics

    • Pharmaceuticals

      • Parasiticides

        • Endectocides

        • Other Parasiticides

      • Anti-infectives 

        • Antimicrobials

        • Anti-infectives except Antimicrobial

      • Anti-inflammatory

      • Analgesics               

      • Hormone Products

      • Others

    • Diagnostics

      • Consumables, reagents and kits

      • Instruments and devices

    • Equipment & Disposables

      • Critical Care Consumables

      • Anesthesia Equipment

      • Fluid Management Equipment

      • Temperature Management Equipment

      • Rescue & Resuscitation Equipment 

      • Research Equipment

      • Patient Monitoring Equipment

    • Medicinal Feed Additives

      • Anticoccidials

      • Performance enhancers (Probiotics + Phytogenics + Others Additives (β-adrenergic agonist)

      • Other

    • Others

      • Veterinary TelehealthVeterinary Software

      • Livestock Monitoring

  • Cattle

    • Biologics

      • Vaccines

        • Modified/ Attenuated Live

        • Inactivated (Killed)

        • Other Vaccines

      • Other Biologics 

        • Artificial Insemination Products (Semen)

        • Reproductive Disease Biologics

        • Respiratory Disease Biologics

        • Other Biologics except AI

      • Pharmaceuticals

        • Parasiticides

          • Ectoparasiticides

          • Endoparasiticides

          • Endectocides

        • Anti-infectives

          • Antimicrobials

          • Anti-infectives except Antimicrobial

        • Anti-inflammatory

        • Analgesics

        • Hormone Products

        • Others

      • Diagnostics

        • Consumables, reagents and kits

        • Instruments and devices

      • Equipment & Disposables

        • Critical Care Consumables

        • Anesthesia Equipment

        • Fluid Management Equipment

        • Temperature Management Equipment

        • Rescue & Resuscitation Equipment

        • Research Equipment

        • Patient Monitoring Equipment

      • Medicinal Feed Additives

        • Oral MFAs

        • Injectable MFAs

      • Others

        • Veterinary Telehealth

        • Veterinary Software

        • Livestock Monitoring

  • Sheep & Goat

    • Biologics

      • Vaccines

        • Modified/ Attenuated Live

        • Inactivated (Killed)

        • Other Vaccines

      • Other Biologics

    • Pharmaceuticals

      • Parasiticides

      • Anti-infectives

      • Anti-inflammatory

      • Analgesics

      • Others

    • Diagnostics

      • Consumables, reagents and kits

      • Instruments and devices

    • Equipment & Disposables

      • Critical Care Consumables

      • Anesthesia Equipment

      • Fluid Management Equipment

      • Temperature Management Equipment

      • Rescue & Resuscitation Equipment

      • Research Equipment

      • Patient Monitoring Equipment

    • Medicinal Feed Additives

    • Others

      • Veterinary Telehealth

      • Veterinary Software

      • Livestock Monitoring

  • Fish

    • Biologics

      • Vaccines

        • Modified/ Attenuated Live

        • Inactivated (Killed)

        • Other Vaccines

      • Other Biologics

    • Pharmaceuticals

      • Parasiticides

      • Anti-infectives

      • Anti-inflammatory  

      • Analgesics 

      • Others 

    • Diagnostics        

      • Consumables, reagents and kits

      • Instruments and devices

    • Equipment & Disposables

      • Critical Care Consumables

      • Anesthesia Equipment

      • Fluid Management Equipment

      • Temperature Management Equipment

      • Rescue & Resuscitation Equipment

      • Research Equipment

      • Patient Monitoring Equipment

    • Medicinal Feed Additives

    • Others

      • Veterinary Telehealth

      • Veterinary Software

      • Livestock Monitoring

• Country Outlook (Revenue, USD Million, 2021 - 2033)

  • Japan

  • China

  • India

  • Indonesia

  • Thailand

  • Australia

  • South Korea

  • Philippines

  • Malaysia

  • Singapore

  • Vietnam

  • Rest of Asia Pacific